reports
Aegon implements increase in share buyback program
Aegon implements increase in share buyback program Schiphol, August 25, 2025 - Aegon today announces that the EUR 200 million share buyback program that began on July 1, 2025, has been increased by EUR 200 million to EUR 400 million with effect as of today. This increase was first announced on , 2025. To date, share repurchases for an aggregate purchase price of EUR 87 million have been completed, representing approximately 43% completion of the initial EUR 200 million program. The increased share buyback is expected to be completed by December 15, 2025, barring unforeseen circumstances. A...
Aegon reports first half year 2025 results
Aegon reports first half year 2025 results Schiphol, August 21, 2025 - Please click to access all 1H 2025 results related documents. 1H 2025 Financial highlights Net profit of EUR 606 million compared with a net loss of EUR 65 million for the first half of 2024Operating result of EUR 845 million, up 19% compared with the first half of 2024, reflecting business growth and improved experience variance in the United States Valuation equity – the sum of shareholders’ equity and the contractual service margin (CSM) after estimated tax adjustment – per share of EUR 8.47; a reduction of 5% i...
- Alicia Reese
- Kade Barr
- Matthew McCartney
Informations sur les droits de vote et les actions au 31 juillet 2025
Informations sur les droits de vote et les actions au 31 juillet 2025 Le 6 août 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext ParisCompartiment : Compartiment ACode ISIN : FR0000054470Site web : Information mensuelle au 31 juillet 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total d’actions composant l...
Christian Dior : Information mensuelle relative au nombre total de dro...
Christian Dior : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Société Européenne au capital de € 361 015 032 - 582 110 987 R.C.S Paris30 avenue Montaigne - 75008 Paris INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL Articles L.233-8 II du Code de commerce et223-16 du Règlement général de l’Autorité des Marchés Financiers Code ISIN : FR0000130403 DateNombre total d’actions composant le capital socialNombre total de droits de vote31 juillet 2025180 507 516Total brut de dro...
- Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
Christian Dior: notice of availability of the half-yearly financial re...
Christian Dior: notice of availability of the half-yearly financial report as of June 30, 2025 NOTICE OF AVAILABILITY OF THEHALF-YEARLY FINANCIAL REPORT AS OF JUNE 30, 2025 Christian Dior half-yearly financial report as of June 30, 2025 (French version) has been filed with the Autorité des Marchés Financiers on July 30, 2025. This document is made available to the public in accordance with applicable regulations and may be found on the Company’s website () under the “Regulated information” heading. Attachment
Christian Dior : communiqué de mise à disposition du rapport financier...
Christian Dior : communiqué de mise à disposition du rapport financier semestriel au 30 juin 2025 COMMUNIQUE DE MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025 Le rapport financier semestriel au 30 juin 2025 a été déposé auprès de l’Autorité des Marchés Financiers le 30 juillet 2025. Ce document est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté dans la rubrique « Informations réglementées » du site internet de la Société (). Pièce jointe
- Pelham Smithers
Christian Dior: Solid results in the first half of 2025 despite the pr...
Christian Dior: Solid results in the first half of 2025 despite the prevailing environment Solid results in the first half of 2025despite the prevailing environment. Revenue: €40 billion. Profit from recurring operations: €9 billion. Free cash flow: €4 billion Paris, July 24, 2025 The Christian Dior Group recorded revenue of €39.8 billion in the first half of 2025. The Group showed good resilience and maintained its powerful innovative momentum despite a disrupted geopolitical and economic environment.Local demand was solid in Europe, which achieved growth on a constant consolidation scop...
Christian Dior : Résultats solides au premier semestre 2025 malgré la...
Christian Dior : Résultats solides au premier semestre 2025 malgré la conjoncture Résultats solides au premier semestre 2025 malgré la conjoncture. Ventes : 40 milliards d’euros. Résultat opérationnel courant : 9 milliards d’euros. Cash flow disponible : 4 milliards d’euros Paris, le 24 juillet 2025 Le groupe Christian Dior réalise au premier semestre 2025 des ventes de 39,8 milliards d’euros. Le Groupe fait preuve d’une bonne résistance et poursuit sa forte dynamique d’innovation malgré un contexte géopolitique et économique perturbé.L’Europe, en progression à devises et périmètre comp...
- Carole Braudeau
Credit Morning 07/23/2025
Auchan: First-half sales are expected to fall by 3.3% in France (Olivier Dauvers)|Retail sales in France fell sharply in June, hit by the heatwave and one less Saturday.|ams OSRAM: € 500m private placement of new 2029 notes, preliminary Q2 figures in line|Unicredit withdraws its bid for Banco BPM and publishes strong Q2 results|
- Carole Braudeau
Morning Crédit 23/07/2025
Auchan : le chiffre d’affaires reculerait de -3,3% en France au S1 (Olivier Dauvers)|Forte baisse des ventes retail en France en juin, pénalisées par la canicule et un samedi de moins|ams OSRAM : placement privé de 500 m EUR d’obligations 2029, chiffres préliminaires au T2 en ligne|Unicredit renonce à son offre sur Banco BPM et publie de solides résultats T2|
- Emmanuel Matot
TEMN TEMENOS AG
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
EXE EXEL INDUSTRIES SA
HCO HIGHCO SA
ABVX ABIVAX SA
SOI SOITEC SA
TIETO TIETOEVRY OYJ
ENC ENCE ENERGIA Y CELULOSA SA
LFDE LA FRANCAISE DE L'ENERGIE SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
ALD ALD SA
MVC METROVACESA SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
DSC1 DUTCH STAR C SHAR
VUL VULCAN ENERGY RESOURCES
- Emmanuel Matot
TEMN TEMENOS AG
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
EXE EXEL INDUSTRIES SA
HCO HIGHCO SA
ABVX ABIVAX SA
SOI SOITEC SA
TIETO TIETOEVRY OYJ
ENC ENCE ENERGIA Y CELULOSA SA
LFDE LA FRANCAISE DE L'ENERGIE SA
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
ALD ALD SA
MVC METROVACESA SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
DSC1 DUTCH STAR C SHAR
VUL VULCAN ENERGY RESOURCES
- Wedbush Research
- Emmanuel Matot
- Alicia Reese
- Kade Barr
- Matthew McCartney
- Emmanuel Matot
Ubisoft reports first-quarter 2025-26 sales
Ubisoft reports first-quarter 2025-26 sales UBISOFT REPORTS FIRST-QUARTER 2025-26 SALES In €mQ12025-26 Reported change vs.Q1 2024-25 % of total net bookings Q1 2025-26 Q1 2024-25 IFRS 15 sales 310.8 -3.9% NA NA Net bookings 281.6 -2.9% NA NA Digital net bookings 250.2 -2.7% 88.8% 88.7% PRI net bookings 151.8 -4.3% 53.9% 54.7% Back-catalog net bookings 260.4 +4.4% 92.5% 86.0% Q1 Net Bookings reached €281.6m, below expectations, reflecting a lower-than-expected performance for Tom Clancy’s Rainbow Six® Siege, a partnership that is now expected to ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.